F P Bymaster

Development of antidepressant drugs. Fluoxetine (Prozac) and other selective serotonin uptake inhibitors.

D. Wong, F. Bymaster, D T Wong, 1995, Advances in experimental medicine and biology.

1,2,5-Thiadiazole analogues of aceclidine as potent m1 muscarinic agonists.

L Jeppesen, J S Ward, F. Bymaster, 1998, Journal of medicinal chemistry.

Therapeutic opportunities for muscarinic receptors in the central nervous system.

F. Bymaster, C. Felder, J. Ward, 2000, Journal of medicinal chemistry.

Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease.

W W Offen, A. Levey, S. Gauthier, 1997, Archives of neurology.

Novel functional M1 selective muscarinic agonists. 2. Synthesis and structure-activity relationships of 3-pyrazinyl-1,2,5,6-tetrahydro-1-methylpyridines. Construction of a molecular model for the M1 pharmacophore.

J S Ward, M L Lamb, F. Bymaster, 1992, Journal of medicinal chemistry.

Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors.

D. Wong, F. Bymaster, P. Threlkeld, 1983, Biochemical pharmacology.

Functionally selective M1 muscarinic agonists. 3. Side chains and azacycles contributing to functional muscarinic selectivity among pyrazinylazacycles.

J S Ward, F. Bymaster, Michael D B Swedberg, 1995, Journal of medicinal chemistry.

Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines .

J S Ward, F. Bymaster, A. Pike, 1992, Journal of medicinal chemistry.